12 Best Long-Term Stocks to Invest in for Retirement

2. AbbVie Inc. (NYSE:ABBV)

Dividend Yield: 3.11%

Number of Hedge Fund Holders: 93

AbbVie Inc. (NYSE:ABBV) is one of the best long-term stocks to invest in for retirement. On February 6, Cantor Fitzgerald reiterated its Overweight rating on AbbVie Inc. (NYSE:ABBV) with a $250 price target. The positive outlook follows solid fourth-quarter 2025 results, as Skyrizi sales topped estimates and the company provided guidance above consensus.

On February 4, AbbVie delivered record net sales in its second full year following the US Humira exclusivity loss. The solid sales numbers underscored the strength of the company’s diversified growth platform. Fourth quarter net revenues were up 10% to $16.61 billion, driven by an 18.3% increase in revenues from the immunology portfolio to $8.63 billion. Diluted EPS in the quarter totaled $1.02.

Full-year net revenues totaled $61.16 billion, up 8.6% year over year. The increase was driven by a 14% increase in revenues in the Immunology portfolio. Adjusted diluted earnings per share totaled $10, representing a 1.2% year over year decrease. AbbVie expects its full-year 2026 earnings per share to range between $14.37 and $14.57.

During the quarter, AbbVie reached an agreement to acquire a device manufacturing facility in Tempe and associated intellectual property in the West. The acquisition should support the development of next-generation immunology and neuroscience medicines.

AbbVie Inc. (NYSE:ABBV) is a global research-driven biopharmaceutical company. It discovers and develops medicines for complex, chronic diseases across immunology, oncology, neuroscience, eye care, and aesthetics.